标题
Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 7, Pages 3677-3693
出版商
American Chemical Society (ACS)
发表日期
2021-03-18
DOI
10.1021/acs.jmedchem.0c01826
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural insight into substrate and inhibitor discrimination by human P-glycoprotein
- (2019) Amer Alam et al. SCIENCE
- Tetrazoles via Multicomponent Reactions
- (2019) Constantinos G. Neochoritis et al. CHEMICAL REVIEWS
- Affinity-Based Protein Profiling Reveals Cellular Targets of Photoreactive Anticancer Inhibitors
- (2019) Nan Ma et al. ACS Chemical Biology
- 477PAn international randomized cross-over bio-equivalence study of oral paclitaxel + HM30181 compared with weekly intravenous (IV) paclitaxel in patients with advanced solid tumours
- (2019) C G C A Jackson et al. ANNALS OF ONCOLOGY
- Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
- (2018) Peter Matzneller et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
- (2018) Amer Alam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation
- (2018) Youngjin Kim et al. SCIENCE
- A phase I study to evaluate safety, tolerability, pharmacokinetics and activity of oraxol in patients (pts) with advanced malignancies.
- (2018) Wen Wee Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- ATP-binding Cassette Exporters: Structure and Mechanism with a Focus on P-glycoprotein and MRP1
- (2017) Maite Rocío Arana et al. CURRENT MEDICINAL CHEMISTRY
- Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature
- (2016) Meaghan Krohe et al. Patient Preference and Adherence
- Multiple Drug Transport Pathways through Human P-Glycoprotein
- (2015) James W. McCormick et al. BIOCHEMISTRY
- Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
- (2015) Tip W. Loo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer
- (2015) K.-W. Lee et al. ONCOLOGIST
- In Vivo Imaging of Multidrug Resistance Using a Third Generation MDR1 Inhibitor
- (2014) Melissa M. Sprachman et al. BIOCONJUGATE CHEMISTRY
- Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers
- (2014) Tae-Eun Kim et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Increased Permeability-Glycoprotein Inhibition at the Human Blood-Brain Barrier Can Be Safely Achieved by Performing PET During Peak Plasma Concentrations of Tariquidar
- (2014) W. C. Kreisl et al. JOURNAL OF NUCLEAR MEDICINE
- A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid Cancer
- (2014) Hyun Jung Lee et al. Cancer Research and Treatment
- Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function
- (2014) Frances Jane Sharom Frontiers in Oncology
- Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants
- (2013) Yu-Jung Cha et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.
- (2013) Ricardo J. Ferreira et al. Journal of Chemical Information and Modeling
- Development and Evaluation of a Novel Microemulsion Formulation of Elacridar to Improve its Bioavailability
- (2013) Ramola Sane et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Refined structures of mouse P-glycoprotein
- (2013) Jingzhi Li et al. PROTEIN SCIENCE
- Tolerability and Pharmacokinetics of a New P-Glycoprotein Inhibitor, HM30181, in Healthy Korean Male Volunteers: Single- and Multiple-Dose Randomized, Placebo-Controlled Studies
- (2012) Tae-Eun Kim et al. CLINICAL THERAPEUTICS
- Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators
- (2009) Ilza K. Pajeva et al. AAPS Journal
- ABC Efflux Pump-Based Resistance to Chemotherapy Drugs
- (2009) Paul D. W. Eckford et al. CHEMICAL REVIEWS
- Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel
- (2009) S L W Koolen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Selective inhibition of MDR1 (ABCB1) by HM30181 increases oral bioavailability and therapeutic efficacy of paclitaxel
- (2009) Jin-Oh Kwak et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
- Paclitaxel and docetaxel in the treatment of breast cancer
- (2008) Emmanouel Saloustros et al. EXPERT OPINION ON PHARMACOTHERAPY
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started